DRA Minisymposium: Optimizing Pharmacotherapy in Practice: The Research Foundation
<typohead type=4 align=left>Thursday, September 16th, 2004 in the Benzon Auditorium</typohead>
The Danish University of Pharmaceutical Sciences Universitetsparken 2, 2100 Copenhagen O
Recent years have witnessed an increased interest in the problems related to prescribing and use of medicines. These problems may threaten the users? health and quality of life and be costly for the individual user and for society. Strategies to improve the rational prescribing and use of medicines have, therefore, come into focus. This symposium aims at presenting the most recent research-based evidence on interventions and their effects. Interventions towards prescribers as well as medicine users will be dealt with.
Program
| 13:00 | Welcome Ebba Holme Hansen, the Danish University of Pharmaceutical Sciences |
| 13:05-13:55 | Outcome of Interventions in Health Care: Lessons Learnt from Research Dennis Ross-Degnan, Associate Professor, Harvard Medical School and Director of Research, Harvard Pilgrim Health Care |
| 13:55-14:30 | National Recommendations for Choice of Prescription Medicines: Basis for the List Jens Peter Kampmann, Director of Institute for Rational Pharmacotherapy |
| 14:30-14:50 | General Practitioners Attempts to Maintain or Raise the Standard of their Prescribing Practices Kristin Henriksen, Assistant Professor, The Danish University of Pharmaceutical Sciences |
| 14:50-15:30 | Coffee Break |
| 15:30-16:20 | Outcomes of Interventions in Pharmacy Practice: Today's Evidence Lisa Bero, Professor, Department of Clinical Pharmacy, University of California |
| 16:20-16:55 | Optimizing Self-medication Practices through Pharmacies Hanne Herborg, Director of Research and Development, Danish Pharmacy College |
| 13:55 | Symposium concludes |
| 17:00 | Reception |
The symposium is open for all interested. No registration required.
Lectures
Dr. Ross-Degnan is one of the global leaders in improving use of medicines. As a member of the Drug Policy Research Group, his research for over two decades has focused on analyzing the impacts of pharmaceutical policies on utilization and clinical outcomes, evaluating behavioral strategies for improving the use of medicines, and developing appropriate methods for studying pharmaceutical use and quality improvement interventions. Dr. Ross-Degnan is also one of the founders of INRUD - the International Network for Rational Use of Drugs.
Professor Bero is a pharmacologist with primary interests in how clinical and basic sciences are translated into clinical practice and health policy. She has developed and validated methods for assessing the quality of research and scientific publication and measuring influences on the quality of research. Professor Bero has conducted analyses to examine the dissemination and policy implications of scientific publications. Among many other activities, she has been the editor for the Cochrane Effective Practice and Organization of Care Group - an international group of researchers conducting meta-analyses of the literature on interventions to change health professional behavior.
Dr. Kampmann is a clinical pharmacologist with many years experience in training doctors in rational pharmacotherapy and carrying out, for example, drug detailing in practice. He is presently the Director of the Danish National Institute for Rational Pharmacotherapy where he has initiated a wide range of activities to improve rationality of medicine use, including the national recommendations for prescription choice.
Dr. Henriksen has conducted research about Danish practitioners? strategies, intentions and emotions involved in prescribing medicines. She has hereby contributed to the knowledge foundation for optimizing rationality of medicine prescribing.
Director Herborg is one of the founders of FKL. She has developed and directed several research projects aiming at improving rational use of medicines through Danish pharmacy practice.
The meeting is organised by: Prof. E. H. Hansen, The Danish University of Pharmaceutical Sciences and Director, FKL - Research Centre for Quality in Medicine Use
